36 min listen
Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?
Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?
ratings:
Length:
37 minutes
Released:
Mar 19, 2024
Format:
Podcast episode
Description
Why does it really matter which GnRH agonist or antagonist you choose for your patient, and how can you use the latest data to inform this decision? Credit available for this activity expires: 3/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000411?ecd=bdc_podcast_libsyn_mscpedu
Released:
Mar 19, 2024
Format:
Podcast episode
Titles in the series (100)
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations: Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME